Osveh Pharmaceutical Company (DOSVE) balance sheet
Assets, liabilities and equity at the close of each period
- Ticker
- DOSVE
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/09/30 | To 1401/09/30 | To 1400/09/30 |
|---|---|---|---|---|---|---|
| Property, plant and equipment | 1,408,603 | 1,374,576 | 1,370,525 | 1,383,578 | 1,025,140 | 624,491 |
| Intangible assets | 2,175 | 2,850 | 4,451 | 6,879 | 14,587 | 0 |
| Long-term investments | 353,366 | 360,654 | 360,139 | 292,139 | 266,278 | 302,445 |
| Long-term receivables | 28,972 | 13,452 | 18,864 | 5,877 | 8,845 | 0 |
| Total non-current assets | 1,793,116 | 1,751,532 | 1,753,979 | 1,688,473 | 1,314,850 | 1,114,324 |
| Orders and prepayments | 783,855 | 239,753 | 308,812 | 1,094,315 | 983,046 | 887,067 |
| Inventory of materials and goods | 2,131,396 | 1,515,409 | 2,286,275 | 2,972,486 | 1,969,633 | 1,422,226 |
| Trade and other receivables | 20,998,650 | 11,195,617 | 11,288,393 | 8,585,166 | 5,862,120 | 4,353,490 |
| Cash | 1,639,223 | 65,591 | 158,498 | 460,121 | 279,488 | 243,009 |
| Total current assets | 25,553,124 | 13,016,370 | 14,041,978 | 13,112,088 | 9,118,935 | 6,908,140 |
| Total assets | 27,346,240 | 14,767,902 | 15,795,957 | 14,800,561 | 10,433,785 | 8,022,464 |
| Capital | 750,000 | 750,000 | 750,000 | 750,000 | 750,000 | 750,000 |
| Legal reserve | 75,000 | 75,000 | 75,000 | 75,000 | 75,000 | 75,000 |
| Retained earnings (accumulated losses) | 13,388,863 | 4,486,545 | 2,782,352 | 4,025,821 | 4,083,165 | 2,730,440 |
| Treasury shares | -20,093 | -31,141 | -30,000 | -30,000 | 0 | 0 |
| Total equity | 14,196,780 | 5,280,404 | 3,577,352 | 4,820,821 | 4,908,165 | 3,555,440 |
| Long-term financial facilities | 1,594,236 | 1,315,196 | 0 | 0 | 0 | 0 |
| Employee end-of-service benefits provision | 919,535 | 563,972 | 418,985 | 302,030 | 213,811 | 134,647 |
| Total non-current liabilities | 2,513,771 | 1,879,168 | 418,985 | 302,030 | 213,811 | 134,647 |
| Trade and other payables | 3,142,049 | 2,386,267 | 4,071,515 | 1,907,235 | 1,166,351 | 781,696 |
| Tax payable | 2,766,281 | 553,506 | 253,787 | 581,434 | 497,988 | 630,798 |
| Dividends payable | 4,727,359 | 3,736,322 | 3,818,955 | 3,532,539 | 2,373,193 | 1,326,351 |
| Total current liabilities | 10,635,689 | 7,608,330 | 11,799,620 | 9,677,710 | 5,311,809 | 4,332,377 |
| Total liabilities | 13,149,460 | 9,487,498 | 12,218,605 | 9,979,740 | 5,525,620 | 4,467,024 |
| Total equity and liabilities | 27,346,240 | 14,767,902 | 15,795,957 | 14,800,561 | 10,433,785 | 8,022,464 |
Reporting periods
77 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.